<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dose-related increase in LVEF with carvedilol in nonischemic cardiomyopathy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dose-related increase in LVEF with carvedilol in nonischemic cardiomyopathy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Dose-related increase in LVEF with carvedilol in nonischemic cardiomyopathy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Change in left ventricular ejection fraction (LVEF) among patients with dilated cardiomyopathy after the administration of carvedilol. There is a dose-related increase in LVEF in those with nonischemic cardiomyopathy; no such dose relationship is seen in patients with ischemic cardiomyopathy.</div><div class="graphic_reference">Data from Bristow MR, Gilbert EM, Abraham WT, et al. Circulation 1996; 94:2807.</div><div id="graphicVersion">Graphic 57443 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
